|For patients with severe SLE who have been deemed appropriate to undergo THA or TKA, continuing the usual dose of mycophenolate mofetil, mycophenolic acid (Myfortic), azathioprine, mizoribine, cyclosporine, or tacrolimus, anifrolumab, and voclosporin through surgery is conditionally recommended.‡|Low|
|For patients with severe SLE undergoing THA or TKA, continuing belimumab and planning surgery in the last month of the dosing cycle of rituximab is conditionally recommended.‡|Low|